Rosuvastatin (Crestor®)
admin December 3rd, 2004
Health Canada have issued an advisory notice about rosuvastatin, following 6 cases of rhabdomyolysis being reported.
Health Canada wishes to advise Canadians of safety concerns about Crestor®, a cholesterol lowering drug, when used at the highest recommended dosage of 40 mg daily. The risk of rhabdomyolysis (muscle breakdown) may be increased at higher doses. Health Canada recommends that all patients taking Crestor®, or any cholesterol lowering drug, should be using the lowest dose that will meet their treatment goal.
- Health Canada
- Comments Off